Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enno Schmidt

Showing results (291-300 of 348) with videos related to

Pageof 35
Sort By:
Frontiers in Immunology|October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Frontiers in Immunology|December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
The Journal of Investigative Dermatology|July 11, 2021
Pathogenic Activation and Therapeutic Blockage of FcαR-Expressing Polymorphonuclear Leukocytes in IgA PemphigusShirin Emtenani, Saeedeh Ghorbanalipoor, Sarah Mayer-Hain, et al.
The Journal of Pathology|March 21, 2012
Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injuryMichael Kasperkiewicz, Falk Nimmerjahn, Sabina Wende, et al.
The Journal of Investigative Dermatology|January 22, 2017
The Leukotriene B<sub>4</sub> and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa AcquisitaTanya Sezin, Matthias Krajewski, Adam Wutkowski, et al.
The Journal of Investigative Dermatology|November 29, 2021
Natural Occurrence of Autoantibodies against Basement Membrane Proteins in Epidermolysis BullosaAntoni Gostyński, Gilles F H Diercks, Maria-José Escamez, et al.
The British Journal of Dermatology|December 22, 2023
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trialNina van Beek, Rüdiger Eming, Alexander Reuss, et al.
JAAD International|March 14, 2025
Antidesmoglein 1 and 3 serum IgG and positivity by direct immunofluorescence microscopy is associated with relapse in pemphigus in a prospective bicontinental studyDipankar De, Shipla Shilpa, Sheetanshu Kumar, et al.
European Journal of Dermatology : EJD|March 11, 2024
Differences among Indian and European pemphigus patients based on demographics, clinical parameters and propensity for relapse: results of a prospective bicontinental cohort studyDipankar De, Shilpa Shilpa, Sheetanshu Kumar, et al.
Frontiers in Immunology|March 3, 2018
Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa AcquisitaUnni K Samavedam, Nina Mitschker, Anika Kasprick, et al.
Pageof 35

Showing results (291-300 of 348) with videos related to

Sort By:
Pageof 35
Frontiers in Immunology|October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Frontiers in Immunology|December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
The Journal of Investigative Dermatology|July 11, 2021
Pathogenic Activation and Therapeutic Blockage of FcαR-Expressing Polymorphonuclear Leukocytes in IgA PemphigusShirin Emtenani, Saeedeh Ghorbanalipoor, Sarah Mayer-Hain, et al.
The Journal of Pathology|March 21, 2012
Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injuryMichael Kasperkiewicz, Falk Nimmerjahn, Sabina Wende, et al.
The Journal of Investigative Dermatology|January 22, 2017
The Leukotriene B<sub>4</sub> and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa AcquisitaTanya Sezin, Matthias Krajewski, Adam Wutkowski, et al.
The Journal of Investigative Dermatology|November 29, 2021
Natural Occurrence of Autoantibodies against Basement Membrane Proteins in Epidermolysis BullosaAntoni Gostyński, Gilles F H Diercks, Maria-José Escamez, et al.
The British Journal of Dermatology|December 22, 2023
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trialNina van Beek, Rüdiger Eming, Alexander Reuss, et al.
JAAD International|March 14, 2025
Antidesmoglein 1 and 3 serum IgG and positivity by direct immunofluorescence microscopy is associated with relapse in pemphigus in a prospective bicontinental studyDipankar De, Shipla Shilpa, Sheetanshu Kumar, et al.
European Journal of Dermatology : EJD|March 11, 2024
Differences among Indian and European pemphigus patients based on demographics, clinical parameters and propensity for relapse: results of a prospective bicontinental cohort studyDipankar De, Shilpa Shilpa, Sheetanshu Kumar, et al.
Frontiers in Immunology|March 3, 2018
Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa AcquisitaUnni K Samavedam, Nina Mitschker, Anika Kasprick, et al.
Pageof 35